Molecular diagnostics market

1. Molecular Diagnostics Market Research Report: Information By Product (Reagents
& Kits, Instruments and Services & Software), By Technique (Polymerase Chain
Reaction (PCR), Isothermal Amplification, Hybridization, Sequencing, Microarray
and others), By Application (Infectious Diseases, Oncology, Genetic Tests and
others), By End User (Hospitals & Clinics, Diagnostic Laboratories and others) -
Global Forecast till 2025
Market Highlights
The Global Molecular Diagnostics Market is expected to register a CAGR of 8.57% during the
forecast period, with a market value of USD 16,319.09 Million by 2025.
Molecular diagnostics is a collection of techniques used to analyze biological markers in
genome and proteome. It helps to diagnose and monitor the diseases and decide which
therapy should be administered to the patient based on the diagnosis. However, the rising
prevalence of the infectious disease, increasing awareness regarding molecular diagnostic
technique, and advancement in molecular diagnostics are the factors responsible for market
growth during the forecast period.
Get Sample Report at
https://www.marketresearchfuture.com/sample_request/1171
Rising prevalence of infectious diseases, advancements in molecular diagnostic techniques,
and increasing prevalence of different types of cancer are likely to contribute to the growth
of the market during the assessment period. For instance, as per a survey carried out by
the World Health Organisation (WHO), around 9.6 million deaths caused by cancer were
recorded in 2018 globally. However, stringent regulatory policies are likely to restrain the
market growth during the forecast period.
Market Players
Market Research Future (MRFR) recognizes the following companies as key players in the
global Molecular Diagnostics Market that include F. Hoffmann-La Roche Ltd (Switzerland),
Hologic, Inc. (US), QIAGEN (Europe), Becton, Dickinson and Company (US), Abbott
Laboratories (US), Cepheid (US), Siemens (Germany), CLONIT SRL (Italy), Thermo Fisher
Scientific(US), Agilent Technologies(California), EKF Diagnostics (UK), Novartis
(Switzerland), and Illumina (US).
Segment Analysis
The global molecular diagnostics market has been segmented into product, technique,
application, and end user. By product, the market has been segregated into reagents & kits,
instruments, and services & software. On the basis of technique, the market has been
divided into polymerase chain reaction (PCR), isothermal amplification, hybridization,
sequencing, microarray, and others. Based on application, the market has been bifurcated
into infectious diseases, oncology, genetic tests, and others. By end user, the market has
been categorized as hospitals & clinics, diagnostic laboratories, and others. The hospitals &
clinics segment accounted for a market value of USD 4.078.09 million in 2018.
Regional Analysis

2. The global molecular diagnostics market, based on region, has been classified as the
Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to
dominate the global molecular diagnostics market during the forecast period. This is
attributed to the increasing geriatric population, and the availability of advanced healthcare
facilities in the region play a vital role in the growth of the regional market. The Europe
market for molecular diagnostics is expected to be the second-largest during the forecast
period. The availability of funds for research & development and rising support from the
government toward the life science sector is expected to boost the growth of the market in
this region.
Additionally, the companies operating in the market are mainly focusing on mergers &
acquisition, which is expected to support market growth. Asia-Pacific is estimated to be the
fastest-growing market due to developing economies such as China, India, and South Korea
emerging as major destinations for the outsourcing of clinical trials, drug manufacturing,
and pathology testing. In addition to this, improving healthcare infrastructure has increased
the number of research activities in the region. Moreover, in Asia-Pacific, China accounted
for a market share of 21.4% in 2018. Furthermore, the market in the Middle East & Africa is
expected to witness steady growth during the review period due to the lack of awareness
regarding healthcare facilities.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/molecular-diagnostics-
market-1171
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com